BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2022

  Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 28, 2022.

  July 5, 2022

   · 

  1 min read
• Transplant Diagnostic Market: Increase in Number of Cancer & Blood Disorder Patients to Drive the Market

  The global transplant diagnostic market was valued at US$ 730.9 Mn in 2017 and is projected to expand at a cumulative annual growth rate of 6.6% from 2018 to 2026 according to a new report published by Transparency Market Research.

  July 5, 2022

   · 

  11 min read
• Orexo’s nasal adrenaline rescue medication OX640 enters clinical development

  Orexo AB, announces it has successfully initiated the first explorative human clinical study for OX640, an adrenaline rescue medication with nasal delivery.

  July 5, 2022

   · 

  4 min read
• Business

  Mogrify and Astellas announce collaboration to conduct research on in vivo regenerative medicine approaches to address sensorineural hearing loss

  Mogrify Limited and Astellas Pharma Inc. announced that they have executed a collaborative research agreement on in vivo regenerative medicine approaches to address sensorineural hearing loss.

  July 5, 2022

   · 

  6 min read
• Drug Development

  Anebulo Pharmaceuticals Announces Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication

  Anebulo Pharmaceuticals, Inc. today announced positive topline data from Part A of an ongoing Phase 2 clinical trial evaluating the potential of ANEB-001 to treat ACI.

  July 5, 2022

   · 

  9 min read
• Business

  CEPI and Codiak BioSciences partner to develop broadly protective Betacoronavirus vaccine

  CEPI, the Coalition for Epidemic Preparedness Innovations, and Codiak BioSciences announced the latest funding award under CEPI’s US $200m programme to advance the development of vaccines that provide broad protection against SARS-CoV-2 and other Betacoronaviruses.

  July 5, 2022

   · 

  7 min read
• Business

  BIOLASE ANNOUNCES SUPPORT FOR TEAMSMILE PROGRAM

  BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced a partnership today with TeamSmile.

  July 5, 2022

   · 

  5 min read
• Deals

  BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION

  Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc.

  July 5, 2022

   · 

  2 min read
• Deals

  Dunes Point Capital, LP Announces the Acquisition of EG Medical

  Dunes Point Capital, LP (“DPC”) has acquired EG Medical.

  July 5, 2022

   · 

  1 min read
• Business

  Lyra Therapeutics Announces Appointment of Richard Nieman, MD, as Chief Medical Officer

  Lyra Therapeutics, Inc today announced that Richard Nieman, MD, has been appointed Chief Medical Officer, effective July 11, 2022.

  July 5, 2022

   · 

  7 min read